News

Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants
RED BANK, NJ / ACCESS Newswire / July 23, 2025 / Tharimmune, Inc. (the “Company” and “Tharimmune”) (Nasdaq Capital ...
The Manila Times12h
Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million
Palisade Bio, Inc. (Nasdaq: PALI) ('Palisade” or the 'Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, ...
Cantech Letter14h
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering
Innocan Pharma Corporation (“Innocan” or the “Company”) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it ...